Antibe Therapeutics Inc (ATBPF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 09-2017 | 06-2017 | 03-2017 | 12-2016 | 09-2016 | |
| Sales | 1,433 | 1,689 | 1,710 | 1,469 | 1,678 |
| Cost of Goods | 906 | 967 | 944 | 832 | 983 |
| Gross Profit | 526 | 722 | 765 | 637 | 695 |
| Operating Expenses | 2,818 | 2,922 | 2,592 | 2,740 | 2,599 |
| Operating Income | -1,386 | -1,233 | -883 | -1,271 | -921 |
| Interest Expense | 106 | 121 | 0 | 164 | 98 |
| Other Income | 4 | 1 | -689 | 165 | 100 |
| Pre-tax Income | -1,487 | -1,353 | -1,571 | -1,270 | -920 |
| Income Tax | -140 | -65 | -336 | 121 | -29 |
| Net Income Continuous | -1,347 | -1,289 | -1,236 | -1,391 | -892 |
| Net Income | $-1,347 | $-1,289 | $-1,236 | $-1,391 | $-892 |
| EPS Basic Total Ops | -0.08 | -0.15 | -0.15 | -0.15 | -0.08 |
| EPS Basic Continuous Ops | -0.09 | -0.11 | -0.11 | -0.14 | -0.10 |
| EPS Diluted Total Ops | -0.08 | -0.15 | -0.15 | -0.15 | -0.08 |
| EPS Diluted Continuous Ops | -0.09 | -0.11 | -0.11 | -0.14 | -0.10 |
| EBITDA(a) | $-1,307 | $-1,165 | $-811 | $-1,034 | $-758 |